Back to Archived Journals » Comparative Effectiveness Research » Volume 8
Corrigendum
Cost-effectiveness of sunitinib as second-line treatment for gastrointestinal stromal tumor in the People’s Republic of China [Corrigendum]
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
5,457 | Dovepress* | 5,457+ | 660 | 6,117 | |
Totals | 5,457 | 660 | 6,117 | ||
*Since 24 January 2018 |
View citations on Google Scholar